Sorafenib induces sustained molecular remission in FLT3-ITD positive AML with relapse after second allogeneic stem cell transplantation without exacerbation of acute GVHD: A case report

Winkler J, Rech D, Kallert S, Rech J, Meidenbauer N, Rösler W, Mackensen A (2010)

Publication Type: Journal article

Publication year: 2010

Journal

Leukemia Research Elsevier

Book Volume: 34

Pages Range: e270-e272

Journal Issue: 10

DOI: 10.1016/j.leukres.2010.04.011

Authors with CRIS profile

Julia Winkler Department of Medicine 5 – Haematology and Oncology Siegfried Kallert Medizinische Fakultät Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology Norbert Meidenbauer Department of Medicine 5 – Haematology and Oncology Wolf Rösler Department of Medicine 5 – Haematology and Oncology Andreas Mackensen Lehrstuhl für Innere Medizin V

How to cite

APA:

Winkler, J., Rech, D., Kallert, S., Rech, J., Meidenbauer, N., Rösler, W., & Mackensen, A. (2010). Sorafenib induces sustained molecular remission in FLT3-ITD positive AML with relapse after second allogeneic stem cell transplantation without exacerbation of acute GVHD: A case report. Leukemia Research, 34(10), e270-e272. https://doi.org/10.1016/j.leukres.2010.04.011

MLA:

Winkler, Julia, et al. "Sorafenib induces sustained molecular remission in FLT3-ITD positive AML with relapse after second allogeneic stem cell transplantation without exacerbation of acute GVHD: A case report." Leukemia Research 34.10 (2010): e270-e272.

BibTeX: Download